🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,413 results for “Chinese” Clear

  1. CM336 (BCMA/CD3 bispecific antibody)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Relapsed Refractory Multiple Myeloma (RRMM)

    phase 1 mab active

    1 trial

  2. CMV-TCR-T cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    CMV Infection or Reactivation After Allogenic HSCT

    phase 1 mab completed

    1 trial

  3. CNCT19 CAR-T cell therapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Autoimmune Hemolytic Anemia

    phase 1 mab active

    1 trial

  4. CRB4101

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy Adult Subjects

    phase 1 small molecule active

    1 trial

  5. CY-219 CAR-T

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Relapsed/Refractory B-cell Lymphoma

    phase 1 small molecule active

    1 trial

  6. Camel milk containing Bifidobacterium animalis A6

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Type 2 Diabetes

    phase 1 other completed

    1 trial

  7. Camrelizumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pancreatic Cancer

    phase 1 small molecule active

    1 trial

  8. Canagliflozin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colorectal Cancer

    phase 1 small molecule active

    1 trial

  9. Cell therapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Periodontal Pocket

    phase 1 other active

    1 trial

  10. Cell therapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Primary Ovarian Insufficiency

    phase 1 gene therapy active

    1 trial

  11. Chinese Herbal Compound Ointment

    The First People's Hospital of Lianyungang

    Atrophic Vaginitis

    phase 1 small molecule active

    1 trial

  12. Chinese tea flavor liquor

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Alcohols

    phase 1 other completed

    1 trial

  13. Citalopram

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Depression

    phase 1 small molecule active

    1 trial

  14. Cordyceps cicadae extract

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Myopia

    phase 1 mab completed

    1 trial

  15. DC-CIK combined with regorafenib ,Iparomlimab and Tuvonralimab Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    DC-CIK Treatment

    phase 1 other active

    1 trial

  16. Daratumumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Aplastic Anemia

    phase 1 small molecule completed

    1 trial

  17. Dasatinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Relapsed AML

    phase 1 small molecule terminated

    1 trial

  18. Donepezil Dihydroxynaphthalate for Injection

    Shanghai University of Traditional Chinese Medicine

    Alzheimer Disease

    phase 1 small molecule active

    1 trial

  19. Dose escalation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Poor Graft Function

    phase 1 mab active

    1 trial

  20. EBV immunological agent

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Malignant Tumor

    phase 1 mab active

    1 trial

  21. ESAT6-CFP10

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy

    phase 1 mab completed

    1 trial

  22. ETH-155008

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    NHL, Adult

    phase 1 small molecule active

    1 trial

  23. ETH-155008

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    NHL

    phase 1 small molecule terminated

    1 trial

  24. EVM16

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Advanced or Recurrent Solid Tumors

    phase 1 mab active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources